Alnylam Pharmaceuticals (ALNY) PT Lowered to $170 at Oppenheimer on Earnings Miss
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $170.00 (from $205.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
